Recombinant monoclonal antibody to CGRP. Eptinezumab is a humanized monoclonal antibody that can be potentially used in the treatment of Migraine. It binds to and inhibits the activity of CGRP.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Please click here for more details about the introduction to mechanism of action, clinical projects and approved drugs of Eptinezumab